Fig. 7From: Effect of switching administration of alendronate after teriparatide for the prevention of BMD loss around the implant after total hip arthroplasty, 2-year follow-up: a randomized controlled trialChange in BMD (%) from baseline in the three patient groups at zone 7 over 2 years. Significant differences were observed between the switch and control groups (P = 0.01) and between ALD and control groups at 2 years (P = 0.03)Back to article page